← FDA Drug Approvals (Drugs@FDA)

CLOFARABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-10-03

Drug application

FDA Application #

ANDA212457

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOFARABINE

Generic name

CLOFARABINE

Active ingredients

CLOFARABINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

EUGIA PHARMA

Manufacturer

Eugia US LLC

First approval

2022-10-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown